Drugs / carbidopa/levodopa
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03665454 Comparator | Sep 2018 → Mar 2019 | Parkinson disease | Milton S. Hershey Medical Center | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | carbidopa/levodopa | “25/100 mg tablet(s) of carbidopa/levodopa will be encapsulated and administered according to the subject's home regimen.” NCT03665454 ↗ |